Cargando…

Pioglitazone Attenuates Atherosclerosis in Diabetic Mice by Inhibition of Receptor for Advanced Glycation End-Product (RAGE) Signaling

BACKGROUND: Peroxisome proliferator-activated receptor-γ (PPAR-γ) exhibits anti-inflammatory and anti-diabetic properties, and is protective against cardiovascular diseases. This study aimed to determine the effects of a PPAR-γ agonist pioglitazone on atherogenesis in an ApoE knockout mouse (ApoE(−/...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gao, Hongli, Li, Hongwei, Li, Weiping, Shen, Xuhua, Di, Beibing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	International Scientific Literature, Inc. 2017
Materias:	Animal Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5749137/ https://www.ncbi.nlm.nih.gov/pubmed/29278639 http://dx.doi.org/10.12659/MSM.907401

Ejemplares similares

Receptor for Advanced Glycation End Products (RAGE) Deficiency Attenuates the Development of Atherosclerosis in Diabetes
por: Soro-Paavonen, Aino, et al.
Publicado: (2008)

High-Mobility Group Box 1 (HMGB1) Induces Migration of Endothelial Progenitor Cell via Receptor for Advanced Glycation End-Products (RAGE)-Dependent PI3K/Akt/eNOS Signaling Pathway
por: Zhang, Yulong, et al.
Publicado: (2019)

Fangchinoline Ameliorates Diabetic Retinopathy by Inhibiting Receptor for Advanced Glycation End-Products (RAGE)-Nuclear Factor Kappa-Light-Chain-Enhancer of Activated B Cells (NF-κB) Pathway in Streptozotocin (STZ)-Induced Diabetic Rats
por: Wu, Qi, et al.
Publicado: (2019)

The Receptor for Advanced Glycation End Products (RAGE) and the Lung
por: Buckley, Stephen T., et al.
Publicado: (2010)

Renal-Protective Effects of the Peroxisome Proliferator-Activated Receptor-γ Agonist Pioglitazone in ob/ob Mice
por: Li, Ying, et al.
Publicado: (2019)

The Receptor for Advanced Glycation End Products (RAGE) Contributes to the Progression of Emphysema in Mice
por: Sambamurthy, Nisha, et al.
Publicado: (2015)

Role of receptor for advanced glycation end products (RAGE) in liver disease
por: Yamagishi, Sho-ichi, et al.
Publicado: (2015)

Hypoxia and the Receptor for Advanced Glycation End Products (RAGE) Signaling in Cancer
por: Taneja, Sakshi, et al.
Publicado: (2021)

Leptin and advanced glycation end products receptor (RAGE) in tuberculosis patients
por: Lazzari, Tássia Kirchmann, et al.
Publicado: (2021)

The Potential Influence of Advanced Glycation End Products and (s)RAGE in Rheumatic Diseases
por: Delrue, Charlotte, et al.
Publicado: (2023)

Receptor for advanced glycation end-products (RAGE) mediates phagocytosis in nonprofessional phagocytes
por: Yang, Yan, et al.
Publicado: (2022)

Pioglitazone attenuates advanced glycation end products‐induced apoptosis and calcification by modulating autophagy in tendon‐derived stem cells
por: Xu, Langhai, et al.
Publicado: (2020)

Receptor for Advanced Glycation End Products (RAGE): A Pivotal Hub in Immune Diseases
por: Yue, Qing, et al.
Publicado: (2022)

The Role of Receptor for Advanced Glycation End Products (RAGE) in the Proliferation of Hepatocellular Carcinoma
por: Yaser, Al-Madhagi, et al.
Publicado: (2012)

The Receptor for Advanced Glycation End Products (RAGE) Is Associated with Persistent Atrial Fibrillation
por: Lancefield, Terase F., et al.
Publicado: (2016)

Receptor for the Advanced Glycation End Products (RAGE) Pathway in Adipose Tissue Metabolism
por: Gutowska, Klaudia, et al.
Publicado: (2023)

Hyperglycemia-Induced Reactive Oxygen Species Increase Expression of the Receptor for Advanced Glycation End Products (RAGE) and RAGE Ligands
por: Yao, Dachun, et al.
Publicado: (2010)

Advanced glycation end products (AGEs) and their receptor (RAGE) induce apoptosis of periodontal ligament fibroblasts
por: Li, D.X., et al.
Publicado: (2014)

Advanced glycation end products accelerate rat vascular calcification through RAGE/oxidative stress
por: Wei, Qin, et al.
Publicado: (2013)

The Receptor for Advanced Glycation End Products (RAGE) Specifically Recognizes Methylglyoxal-Derived AGEs
por: Xue, Jing, et al.
Publicado: (2014)

Characterization of advanced glycation end products and their receptor (RAGE) in an animal model of myocardial infarction
por: Fracasso, Bianca de Moraes, et al.
Publicado: (2019)

Soluble receptor for advanced glycation end products (sRAGE) as a biomarker of COPD
por: Pratte, Katherine A., et al.
Publicado: (2021)

Dysregulation of Receptor for Advanced Glycation End Products (RAGE) Expression as a Biomarker of Keratoconus
por: Navel, Valentin, et al.
Publicado: (2022)

Polymorphisms −374 T/A and −429 T/C of the Receptor for Advanced Glycation End-Products (RAGE) and Serum Levels of RAGE (sRAGE) Are Not Associated with Metabolic Syndrome
por: González-Guerrero, Diana Elizabeth, et al.
Publicado: (2023)

Adiponectin Abates Atherosclerosis by Reducing Oxidative Stress
por: Wang, Xuemei, et al.
Publicado: (2014)

RAGE (Receptor for Advanced Glycation Endproducts), RAGE Ligands, and their role in Cancer and Inflammation
por: Sparvero, Louis J, et al.
Publicado: (2009)

Association of soluble receptor for advanced glycation end-products (sRAGE) serum on COVID-19 severity: A cross-sectional study
por: Saputra, Gusti Noor Ramadany, et al.
Publicado: (2022)

In Patients with Chronic Kidney Disease Advanced Glycation End-Products Receptors Isoforms (sRAGE and esRAGE) Are Associated with Malnutrition
por: Caldiroli, Lara, et al.
Publicado: (2022)

Pioglitazone inhibits high glucose-induced expression of receptor for advanced glycation end products in coronary artery smooth muscle cells
por: DI, BEI-BING, et al.
Publicado: (2015)

Plasma Levels of Soluble Receptor for Advanced Glycation End Products and Coronary Atherosclerosis: Possible Correlation with Clinical Presentation
por: Falcone, Colomba, et al.
Publicado: (2013)

Receptor for Advanced Glycation End Products (RAGE) and Its Ligands: Focus on Spinal Cord Injury
por: Song, Juhyun, et al.
Publicado: (2014)

The Receptor for Advanced Glycation End Products (RAGE) Affects T Cell Differentiation in OVA Induced Asthma
por: Akirav, Eitan M., et al.
Publicado: (2014)

Relevance of Receptor for Advanced Glycation end Products (RAGE) in Murine Antibody-Mediated Autoimmune Diseases
por: Eichhorst, Alexandra, et al.
Publicado: (2019)

Modulation of soluble receptor for advanced glycation end-products (RAGE) isoforms and their ligands in healthy aging
por: Scavello, Francesco, et al.
Publicado: (2019)

Characterization of αX I-Domain Binding to Receptors for Advanced Glycation End Products (RAGE)
por: Buyannemekh, Dolgorsuren, et al.
Publicado: (2017)

Therapeutic potential of targeting the receptor for advanced glycation end products (RAGE) by small molecule inhibitors
por: Singh, Harbinder, et al.
Publicado: (2022)

Receptors for Advanced Glycation End Products (RAGE): Promising Targets Aiming at the Treatment of Neurodegenerative Conditions
por: Koerich, Suélyn, et al.
Publicado: (2023)

Leonurine Attenuates Hyperalgesia in Mice with Induced Adenomyosis
por: Nie, Jichan, et al.
Publicado: (2017)

Advanced glycation end products correlate with breast cancer metastasis by activating RAGE/TLR4 signaling
por: Pan, Shuo, et al.
Publicado: (2022)

The role of receptor for advanced glycation endproducts (RAGE) in infection
por: van Zoelen , Marieke AD, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_o7fjciqg8ik0hct4vea47iq6ji